000 | 01292cam a22003257i 4500 | ||
---|---|---|---|
001 | 17972505 | ||
005 | 20220527073652.0 | ||
008 | 131216s2013 ne af b 001 0 eng d | ||
010 | _a 2012276020 | ||
015 |
_aGBB358839 _2bnb |
||
016 | 7 |
_a016448231 _2Uk |
|
020 | _a9780123948106 | ||
020 | _a012394810X | ||
035 | _a(OCoLC)ocn852806062 | ||
040 |
_aUKMGB _beng _cUKMGB _erda _dOCLCO _dIXA _dDLC |
||
042 | _alccopycat | ||
050 | 0 | 0 |
_aRM301.4 _b.N66 2013 |
082 | 0 | 4 |
_a615.7 _223 |
245 | 0 | 0 |
_aNonclinical development of novel biologics, biosimilars, vaccines and specialty biologics / _cedited by Lisa M. Plitnick, MS, PhD and Danuta J. Herzyk, PhD, Merck Research Laboratories, Merck & Co., Inc. West Point, PA, USA. |
300 |
_axv, 416 pages, 8 unnumbered pages of plates : _billustrations (some color) ; _c25 cm |
||
504 | _aIncludes bibliographical references and index. | ||
650 | 0 |
_aBiopharmaceutics. _98539 |
|
650 | 0 |
_aBiologicals. _98540 |
|
650 | 0 |
_aBiological products. _98541 |
|
700 | 1 |
_aPlitnick, Lisa M., _eeditor of compilation. _98542 |
|
700 | 1 |
_aHerzyk, Danuta J., _eeditor of compilation. _98543 |
|
906 |
_a7 _bcbc _ccopycat _d2 _encip _f20 _gy-gencatlg |
||
942 |
_2ddc _cBK |
||
999 |
_c2563 _d2563 |